Activation of VIPR1 suppresses hepatocellular carcinoma progression by regulating arginine and pyrimidine metabolism

Background and aims: Vasoactive intestinal polypeptide type-I receptor (VIPR1) overexpression has been reported in numerous types of malignancies and utilized to develop novel target therapeutics and radiolabeled VIP analogue-based tumor imaging technology, but its role in liver carcinogenesis has n...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Yaojie, Liu, Shanshan, Rodrigues, Robim M., Han, Ying, Guo, Cao, Zhu, Zhanwei, He, Yong, Mackowiak, Bryan, Feng, Dechun, Gao, Bin, Zeng, Shan, Shen, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295067/
https://www.ncbi.nlm.nih.gov/pubmed/35864952
http://dx.doi.org/10.7150/ijbs.71134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295067/
https://www.ncbi.nlm.nih.gov/pubmed/35864952
http://dx.doi.org/10.7150/ijbs.71134

Ejemplares similares